ACHILLES THERAPEUTICS PL-ADR (ACHL)
US00449L1026 - ADR
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -69.67M | -71.18M | -61.10M | -33.20M | -13.99M | |||
| Depreciation Amortization | 4.71M | 3.69M | 3.29M | 770.00K | 300.00K | |||
| Income Taxes - Deferred | 210.00K | -230.00K | -20.00K | 0.00 | 0.00 | |||
| Change In Working Capital | 9.97M | -6.33M | -7.93M | 4.19M | -1.19M | |||
| Taxes Paid | 626.00K | N/A | N/A | N/A | N/A | |||
| Other non cash items | 6.33M | 14.51M | 6.48M | 2.99M | 730.00K | |||
| OPERATING CASH FLOW | -48.45M | -59.54M | -59.28M | -25.25M | -14.14M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.10M | -7.51M | -7.63M | -11.85M | -940.00K | |||
| INVESTING CASH FLOW | -1.10M | -7.51M | -7.63M | -11.85M | -940.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 9.00K | 0.00 | 160.76M | 113.83M | 93.62M | |||
| Other Financing Activity | 0.00 | 0.00 | 0.00 | -120.00K | 0.00 | |||
| FINANCING CASH FLOW | 9.00K | 0.00 | 160.76M | 113.70M | 93.62M | |||
| Exchange Rate Effect | 7.74M | -25.94M | -5.33M | 3.65M | 8.37M | |||
| CHANGE IN CASH | -41.80M | -92.99M | 88.52M | 80.25M | 86.91M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -48.45M | -59.54M | -59.28M | -25.25M | -14.14M | |||
| Capital Expenditure | -1.10M | -7.51M | -7.63M | -11.85M | -940.00K | |||
| FREE CASH FLOW | -49.55M | -67.05M | -66.91M | -37.10M | -15.08M | |||
All data in USD